Cullgen shanghai inc
WebFeb 25, 2024 · San Diego and Shanghai (February 25, 2024) – Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein degradation technology, today announced that it has closed a $50 million Series B financing WebWho is Cullgen Headquarters 12730 High Bluff Dr Ste 250, San Diego, California, 92130, United States Phone Number (858) 284-0115 Website www.cullgen.com Revenue $27.6M Industry Pharmaceuticals Healthcare Cullgen's Social Media Is this data correct? View contact profiles from Cullgen Popular Searches Cullgen cullgen Inc SIC Code 28,283
Cullgen shanghai inc
Did you know?
WebYing Luo Age : 57 Public asset : 11,457,135 USD Linked companies : GNI Group Ltd. - Catalyst Biosciences, Inc. Summary Ying Luo is an entrepreneur and businessperson who founded GNI Group Ltd., Shanghai Genomics, Inc. and Cullgen, Inc. and who has been the head of 10 different companies. WebFeb 9, 2024 · 简介：上海睿跃生物科技有限公司成立于2024-02-09，法定代表人为LUO YING，注册资本为50000万元人民币，统一社会信用代码为91310115MA1H8M155X，企业地址位于上海市浦东新区川宏路230号6幢第1层、第2层、第3层，所属行业为科技推广和应用服务业，经营范围包含：一般项目：从事生物科技（除人体干细胞、基因诊断与治疗技 …
WebCBIO：Catalyst Biosciences, Inc. BAB：Berkeley Advanced Biomaterials LLC. Cullgen: Cullgen Inc.およびCullgen Shanghai, Inc. （下記の全ての質問は、代表執行役社長のイン・ルオ博士により回答されました。） Q1：F351の臨床試験の進行状況について教えてくだ … WebCullgen has raised a total of $66M in funding over 3 rounds. Their latest funding was raised on Feb 25, 2024 from a Series B round. Cullgen is funded by 8 investors. Heights Capital Management and South China Venture Capital are the most recent investors.
WebCullgen Inc. 230 Chuan Hong Road, Bldg 6. Pu Dong New Area, Shanghai, China, 201202. Tel: +86-21-5080 2786 Fax：+86-21-5080 2783 WebSAN DIEGO--(BUSINESS WIRE)--Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of …
WebFeb 25, 2024 · SAN DIEGO & SHANGHAI-- ( BUSINESS WIRE )-- Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein degradation technology, today announced that it has closed a $50 million Series B financing (assuming exercise of warrant).
WebApr 10, 2024 · Cullgenは、GNIによる初期投資を経てYue Xiong博士とJian Jin博士により2024年3月に設立されて以降、その評価額は今回のシリーズA投資までに70％増加し ... flower pakistanWebCullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders for the treatment of diseases lacking effective therapeutic approaches. … green and black ll bean flannelWebThomas Eastling concurrently serves as Chief Financial Officer of Cullgen Inc. in San Diego. He previously served as Chief Financial Officer of the GNI Group from 2013 to 2024. He has over 35 years' experience in global finance, M&A and executive management with senior postings in New York, London, Tokyo and Hong Kong. Mr. flower paintings next to vasesWebCullgen Inc. Cullgen is a privately held biopharmaceutical company dedicated to the development of first-in-class new chemical entities (NCEs) for the treatment of diseases lacking effective therapeutic approaches. We are developing our proprietary technology platform, ... center in Shanghai, China. Job Accountabilities: green and black meaningWebJan 21, 2024 · Cullgen Inc. May 2024 - Oct 2024 6 months. Shanghai, China -Exploring PROTAC to target selective disease-causing proteins for the degradation by the UPS. -Drud discoveries: Developing CRL4(DCAF15 ... green and black leopard backgroundgreen and black motherboard gaming windows 10WebSan Diego and Shanghai (February 25, 2024) – Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ … green and black lightning